LAM IND Share Price Other OTC
Equities
US51280R1041
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2019 | 1.56M 130M | Sales 2020 | - | Capitalization | 807K 67.43M |
---|---|---|---|---|---|
Net income 2019 | - 0 | Net income 2020 | - 0 | EV / Sales 2019 | 6.27 x |
Net Debt 2019 | 8.41M 703M | Net Debt 2020 | 2.48M 207M | EV / Sales 2020 | - |
P/E ratio 2019 |
-4.17
x | P/E ratio 2020 |
-4.29
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30/15/30 |
Vince Demasi
COO | Chief Operating Officer | - | 20/18/20 |
Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30/15/30 |
John Guerra
SEC | Corporate Secretary | - | 31/13/31 |
Vince Demasi
COO | Chief Operating Officer | - | 20/18/20 |
1st Jan change | Capi. | |
---|---|---|
+20.03% | 126B | |
+23.61% | 118B | |
+23.26% | 27.87B | |
-18.07% | 20.95B | |
-15.13% | 16.92B | |
-14.81% | 16.18B | |
+9.78% | 14.84B | |
-46.10% | 14.79B | |
+52.34% | 14.08B |